Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

The company recently released phase 3 data showing that a twice-yearly treatment with lenacapavir was 100% effective in HIV ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...

"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...

The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...